Continental Chemicals Limited has announced the resignation of its Chief Financial Officer Mr. Navneet Kumar, effective January 14, 2026. The announcement was made through a regulatory filing under Regulation 30 of SEBI (LODR) Regulations, 2015, dated January 12, 2026.

Resignation Details

Mr. Navneet Kumar submitted his resignation from the position of CFO and Key Managerial Person (KMP) on December 13, 2025. The resignation was attributed to personal reasons, specifically his decision to pursue another career opportunity. The Board of Directors took note of the resignation during their meeting held on Monday, January 12, 2026.

The key details of the resignation are summarized below:

Regulatory Compliance

The company has fulfilled its disclosure obligations pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, read with Schedule III of the said regulations. Continental Chemicals Limited confirmed that there are no other material reasons for Mr. Kumar's resignation beyond those stated in the official communication.

The disclosure was signed by Company Secretary Ms. Sakshi Dhawan (Membership No: ACS 33279) and submitted to the Bombay Stock Exchange, where the company's scrip code is 506935.

Succession Planning

The Board of Directors has indicated that they will appoint Mr. Kumar's successor in due course. The company has not provided a specific timeline for the appointment of the new CFO, but the transition is expected to be managed smoothly given the advance notice period provided.

This leadership change comes as part of the natural evolution of the company's management structure, with the departing CFO pursuing new career opportunities in the industry.

Continental Chemicals Limited has submitted its quarterly compliance report to the Bombay Stock Exchange, detailing the utilization of funds raised through preferential issue for the quarter ended December 31, 2025. The filing, made pursuant to Regulation 32 of SEBI (LODR) Regulations, 2015, confirms adherence to regulatory disclosure requirements.

Fund Raising Details

The company's preferential issue was completed on October 14, 2019, raising ₹1.63 crore for working capital requirements. The filing provides a comprehensive overview of how these funds have been deployed over the years since the initial raising.

Compliance and Utilization Status

The quarterly statement confirms that there has been no deviation or variation in the use of funds raised through the preferential issue. The company has maintained its original allocation strategy, with all funds directed toward working capital as initially disclosed to investors.

Key compliance highlights include:

• No deviation from original fund utilization objectives
• No changes in terms of contract or objects requiring shareholder approval
• Audit committee review and approval completed
• Full fund utilization achieved in quarter ended December 31, 2023

Regulatory Framework

The filing demonstrates Continental Chemicals' commitment to maintaining transparency in fund utilization reporting. Under SEBI regulations, listed companies must regularly disclose any deviations or variations in the use of funds raised from the public or through preferential allotments.

The statement was signed by Company Secretary Sakshi Dhawan and Managing Director Naresh Kumar Chibba, confirming the accuracy of the reported information. This quarterly filing reinforces the company's adherence to corporate governance standards and regulatory compliance requirements in the Indian capital markets.